Now online! STING reprogramming by estrogen promotes neutrophil extracellular trap formation and sex-biased resistance to ADC therapy
dlvr.it
STING reprogramming by estrogen promotes neutrophil extracellular trap formation and sex-biased resistance to ADC therapy
Sex differences in antibody-based cancer therapy remain poorly understood. This study identifies estrogen-driven STING reprogramming and neutrophil extracellular trap formation as a mechanism of functional antigen shielding that limits ADC efficacy.